BAYLOR COLLEGE OF MEDICINE
Rewired Metabolism and Immunosuppression in MYCN-driven Neuroblastoma
Rewired Metabolism and Immunosuppression in MYCN-driven Neuroblastoma is a funding opportunity from BAYLOR COLLEGE OF MEDICINE, up to 418553, closing July 31, 2029.
Jul 31, 2029
(1096d left)Overview
PROJECT SUMMARY Amplification of the oncogene MYCN drives high-risk progressive disease, resistance to therapy, and a poor overall survival rate below 45% for high-risk neuroblastoma (NB) patients. Further, more than half of all high-risk patients will relapse, and the post-relapse survival rate is only 10%.…